-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018646-gance-cleveland-final-report-2014.pdf
January 01, 2014 - with being
overweight or obese as an adult,2 as well as having increased risk for hyperlipidemia, diabetes … and
are extrapolated from experience with the National Health Disparities Collaboratives on Asthma, Diabetes … Medical assessment covered
screening for a variety of conditions such as hypertension, type 2 diabetes … School-based health center providers’
treatment of childhood overweight. … School-based health center providers' treatment of
overweight children.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/2023-annual-report-to-congress.pdf
January 01, 2023 - • For suicide risk, more research is needed on the effectiveness of screening tests and treatments … • For all conditions, evidence is lacking on the most effective tools and treatments for screening … affect an individual’s physical health, placing them at greater risk of chronic health conditions like diabetes … Hispanic/Latino persons or persons with depression, may
help determine whether culturally tailored therapies … persons or persons with depression, which may help determine the effectiveness of
culturally tailored therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
June 01, 2014 - EHC program
research in the form
of free research
summaries about the benefits and risks of treatments … Sharing knowledge and working together to determine the best steps
for treatment and recovery will … This knowledge will
empower the patient and guardian with best practices for diagnosis and treatment … Finally, providing consistency in
diagnosis and treatment and patient education throughout the retail … So for instance, like the National Kidney Disease Education Program
and the National
Diabetes Education
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
December 14, 2017 - The review "does not cover preoperative or adjunctive
treatments." … Public Reviewer
(Allergen)
Background The first US Phase III trial indicates that medical therapy … system, eye care, medical aesthetics, gastroenterology,
urology, cardiovascular, and anti-infective therapeutic … between very different
treatments. … In many conditions for where direct marketing to consumers is
common (diabetes, back surgery, orthopedic
-
hcup-us.ahrq.gov/reports/methods/2011_03.pdf
January 01, 2011 - However, those based on all-listed DX
include a number of common chronic conditions (e.g., hypertension, diabetes … , those
based on all-listed DX include a number of common chronic conditions (e.g., hypertension,
diabetes … Patients receiving therapeutic services only
For patients receiving therapeutic services only during … diagnosis, either condition may
be sequenced first, unless the circumstances of the admission, the therapy … for
principal diagnosis as determined by the circumstances of admission, diagnostic
workup and/or therapy
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
January 01, 2007 - PROC W/O CC 54 0.00
294: DIABETES AGE >35 35,236 1.11
295: DIABETES AGE 0-35 13,281 0.42
296: NUTRITIONAL … PROC W/O CC/MCC 23 0.00
637: DIABETES W MCC 3,028 0.29
638: DIABETES W CC 6,082 0.58
639: DIABETES … W MCC 937 0.09
920: COMPLICATIONS OF TREATMENT W CC 1,339 0.13
921: COMPLICATIONS OF TREATMENT W/O … 9,716 0.23
146: Treatment; fracture or dislocation of hip and femur 49,754 1.18
147: Treatment; fracture … radiology for cancer treatment 3,721 0.09
212: Diagnostic physical therapy 554 0.01
213: Physical
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
April 09, 2010 - PROC W/O CC 48 0.00
294: DIABETES AGE >35 34,160 1.09
295: DIABETES AGE 0-35 13,323 0.43
296: NUTRITIONAL … PROC W/O CC/MCC 19 0.00
637: DIABETES W MCC 2,964 0.29
638: DIABETES W CC 5,866 0.57
639: DIABETES … W MCC 932 0.09
920: COMPLICATIONS OF TREATMENT W CC 1,352 0.13
921: COMPLICATIONS OF TREATMENT W/O … 9,650 0.23
146: Treatment; fracture or dislocation of hip and femur 50,372 1.21
147: Treatment; fracture … radiology for cancer treatment 3,820 0.09
212: Diagnostic physical therapy 396 0.01
213: Physical
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/physical-activity-behavioral-counseling-primary-care-2002
July 01, 2002 - Regular physical activity helps prevent cardiovascular disease, hypertension, type 2 diabetes … increased risks for many chronic diseases and conditions, including cardiovascular disease, hypertension, diabetes … examining the effectiveness of physical activity counseling for children or adolescents that compared treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparison of lumiracoxib with naproxen and
ibuprofen in the Therapeutic Arthritis Research and
Gastrointestinal … Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and
patient … Alimentary Pharmacology & Therapeutics. 20(1):51-63, 2004 Jul 1.
Appendix F. … assessed pain measurement with
adequate power (70%) to detect minimum clinical difference between treatments … with
drugs having a
therapeutic
effecton the
knee joint)
no yes Dolorgiet
Pharmaceuticals
(Germany
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
August 03, 2011 - which are manifestations of disease processes,
and disabilities that are iatrogenically acquired from treatments … AHRQ noted that “[c]ommon health
conditions that can be profoundly disabling include some, such as diabetes … o Diabetes complications
o Bacterial pneumonia
o Asthma
o Gastroenteritis
o Hypertension … We will search MEDLINE, EPOC (for organizational quality improvement efforts), PEDRO
(physical therapy … Physical
Therapy 2006, 86(5):726-734
VI.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - Just as a
screening tes tfor diabetes is sensitive, the person
would still be ill without a plan to … Are the same treatments known to be effective in
general population similarly effective among women … depression and
other outcomes without linking to screening; is there
strong evidence for effective treatments … While treatments for
postpartum depression are beyond the scope of
this review, we agree that questions … Just as a screening instrument for
diabetes is sensitive, the person would still be ill
without a plan
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
October 04, 2016 - are managed with multiple medications that may
include inhaled, orally administered, and biologic therapeutics … The guidelines
address the diagnosis, evaluation, and treatment of asthma. … allergen(s)
§ Reduction or elimination of exposure to multiple indoor inhalant allergens
o KQ 2
§ Treatments … studies are likely to underrepresent racial minorities, patients with substantial
comorbidities (such as diabetes … Available: http://www.aaaai.org/conditions-and-treatments/asthma.
7. Gotzsche PC, Johansen HK.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
October 01, 2010 - this article is to summarize our recommendations in conducting quantitative synthesis of
CERs for therapeutic … population less comparable over time, while the effectiveness of the
initial highly-active antiretroviral therapy … Two treatments are suggested to have comparable effectiveness if their direct effects vs. a common … Simultaneous comparison of multiple
treatments: combining direct and indirect
evidence. … Initial
highly-active antiretroviral therapy with a
protease inhibitor versus a non-nucleoside
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
October 01, 2010 - this article is to summarize our recommendations in conducting quantitative synthesis of
CERs for therapeutic … population less comparable over time, while the effectiveness of the
initial highly-active antiretroviral therapy … Two treatments are suggested to have comparable effectiveness if their direct effects vs. a common … Simultaneous comparison of multiple
treatments: combining direct and indirect
evidence. … Initial
highly-active antiretroviral therapy with a
protease inhibitor versus a non-nucleoside
-
hcup-us.ahrq.gov/reports/statbriefs/sb299-Hospital-Stays-Children-2019.pdf
January 01, 2019 - Skin and subcutaneous tissue
infections 8 3.5 6 2.7
Encounter for antineoplastic therapies … 10 2.4
Appendicitis and other appendiceal
conditions 4 5.2 2 5.3 5 2.6
Diabetes … estimates only
and enables analyses of rare conditions (such as congenital anomalies) and uncommon treatments … NHEA spending
or revenue measures the amount of income received by the hospital for treatment and other … quality of health
services, medical practice patterns, access to healthcare programs, and outcomes of treatments
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/module-1-slides.pdf
January 30, 2020 - help patients with medication adherence;
management of weight loss, smoking cessation,
hypertension, diabetes … and long-term care
utilization
• CR is a relatively low-cost intervention compared
to inpatient treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
May 29, 2025 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
May 29, 2025 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments